685
Views
75
CrossRef citations to date
0
Altmetric
Review

Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review

, , &
Pages 17-29 | Published online: 17 Jan 2013

References

  • Landsman A Taft D Riemer K The role of collagen bioscaffolds, foamed collagen, and living skin equivalents in wound healing Clin Podiatr. Med Surg 2009 26 4 525 533 19778686
  • Cullen B Watt PW Lundqvist C The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action Int J Biochem Cell Biol 2002 34 12 1544 1556 12379277
  • Mustoe TA O’Shaughnessy K Kloeters O Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis Plast Reconstr Surg 2006 117 Suppl 7 S35 S41
  • Lavery LA Armstrong DG Murdoch DP Peters EJ Lipsky BA Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system Clin Infect Dis 2007 44 4 562 565 17243061
  • Prompers L Huijberts M Apelqvist J High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study Diabetologia 2007 50 1 18 25 17093942
  • Patti J Boles JO Höök M Identification and biochemical characterization of the ligand binding domain of the collagen adhesin from Staphylococcus aureus Biochemistry 1993 32 42 11428 11435 8218209
  • Rich RL Kreikemeyer B Owens RT Ace is a collagen-binding MSCRAMM from Enterococcus faecalis J Biol Chem 1999 274 38 26939 26945 10480905
  • Lannergård J Frykberg L Guss B CNE, a collagen-binding protein of Streptococcus equi FEMS Microbiol Lett 2003 222 1 69 74 12757948
  • Patti J Allen BL McGavin MJ Höök M MSCRAMM-mediated adherence of microorganisms to host tissues Annu Rev Microbiol 1994 48 585 617 7826020
  • Hienz S Schennings T Heimdahl A Flock JI Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis J Infect Dis 1996 174 1 83 88 8656018
  • Mamo W Fröman G Muller HP Protection induced in mice vaccinated with recombinant collagen-binding protein (CnBP) and alpha-toxoid against intramammary infection with Staphylococcus aureus Microbiol Immunol 2000 44 5 381 384 10888356
  • Rhem MN Lech EM Patti JM The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis Infect Immun 2000 68 6 3776 3779 10816547
  • Elasri MO Thoma JR Skinner RA Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis Bone 2002 30 1 275 280 11792597
  • Gottrup F Controversies in performing a randomized control trial and a systemic review Wound Repair Regen 2012 20 4 447 448 22672196
  • Hinchliffe RJ Valk GD Apelqvist J A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes Diabetes Metab Res Rev 2008 24 Suppl 1 S119 S144 18442185
  • Game FL Hinchliffe RJ Apelqvist J A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes Diabetes Metab Res Rev 2012 28 Suppl 1 S119 S141
  • Gottrup F Apelqvist J Price P for European Wound Management Association Patient Outcome Group Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management J Wound Care 2010 19 6 237 268 20551864
  • Boulton AJ Armstrong DG Trials in neuropathic diabetic foot ulceration: time for a paradigm shift? Diabetes Care 2003 26 9 2689 2690 12941739
  • Margolis DJ Kantor J Berlin JA Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis Diabetes Care 1999 22 5 692 695 10332667
  • Brem H Balledux J Bloom T Kerstein MD Hollier L Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing Arch Surg 2000 135 6 627 634 10843357
  • Edmonds M for European and Australian Apligraf Diabetic Foot Ulcer Study Group Apligraf in the treatment of neuropathic diabetic foot ulcers Int J Low Extrem Wounds 2009 8 1 11 18 19189997
  • Sams HH Chen J King LE Graftskin treatment of difficult to heal diabetic foot ulcers: one center’s experience Dermatol Surg 2002 28 8 698 703 12174061
  • Veves A Falanga V Armstrong DG Sabolinski ML for Apligraf Diabetic Foot Ulcer Study Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial Diabetes Care 2001 24 2 290 295 11213881
  • Brem H Young J Tomic-Canic M Isaacs C Erlich HP Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers Surg Technol Int 2003 11 23 31 12931279
  • Steinberg JS Edmonds M Hurley DPJr King WN Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers J Am Podiatr Med Assoc 2010 100 1 73 77 20093548
  • Naughton G Mansbridge J Gentzkow G A metabolically active human dermal replacement for the treatment of diabetic foot ulcers Artif Organs 1997 21 11 1203 1210 9384327
  • Gentzkow GD Iwasaki SD Hershon KS Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers Diabetes Care 1996 19 4 350 354 8729158
  • Kashefsky HE Outcomes of total contact casting combined with dermagraft in the treatment of 15 consecutive diabetic foot ulcers Wound Repair Regen 2011 19 2 A31
  • Brigido SA The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study Int Wound J 2006 3 3 181 187 16984575
  • Martin BR Sangalang M Wu S Armstrong DG Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience Int Wound J 2005 2 2 161 165 16722865
  • Landsman A Roukis TS DeFonzo DJ Agnew P Petranto RD Surprenant M Living cells or collagen matrix: Which is more beneficial in the treatment of diabetic foot ulcers? Wounds 2008 20 5 111 116
  • Iorio ML Goldstein J Adams M Steinberg J Attinger C Functional limb salvage in the diabetic patient: the use of a collagen bilayer matrix and risk factors for amputation Plast Reconstr Surg 2011 127 1 260 267 20938372
  • Fleischli JG Laughlin TJ Fleischli JW Equine pericardium collagen wound dressing in the treatment of the neuropathic diabetic foot wound: a pilot study J Am Podiatr Med Assoc 2009 99 4 301 305 19605923
  • Clerici G Caminiti M Curci V Quarantiello A Faglia E The use of a dermal substitute to preserve maximal foot length in diabetic foot wounds with tendon and bone exposure following urgent surgical debridement for acute infection Int Wound J 2010 7 3 176 183 20602648
  • Liao HC Huang HS Huang MJ Chen CC Preliminary experience with growth factor and porcine graft-young collagenous wettable membrane in the treatment of chronic diabetic ulcer Changgeng Yi Xue Za Zhi 1991 14 2 89 94 1878811
  • Parsons D Bowler PG Myles V Jones S Silver antimicrobial dressings in wound management: a comparison of antibacterial, physical, and chemical characteristic Wounds 2005 17 8 222 232
  • Chaw KC Manimaran M Tay FE Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms Antimicrob Agents Chemother 2005 49 12 4853 4859 16304145
  • Kostenko V Lyczak J Turner K Martinuzzi RJ Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment Antimicrob Agents Chemotherapy 2010 54 12 5120 5131
  • Thorn RM Austin AJ Greenman J Wilkins JP Davies PJ In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms J Wound Care 2009 18 8 343 346 19862874
  • Percival SL Bowler P Woods EJ Assessing the effect of an antimicrobial wound dressing on biofilms Wound Repair Regen 2008 16 1 52 57 18211579
  • Gottrup F Collagen/ORC/silver treatment of diabetic foot ulcers: A randomised controlled trial Wound Repair Regen 2011 19 2 A24
  • Ulrich D Smeets R Unglaub F Wöltje M Pallua N Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers J Wound Ostomy Continence Nurs 2011 38 5 522 528 21860331
  • Donaghue VM Chrzan JS Rosenblum BI Giurini JM Habershaw GM Veves A Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers Adv Wound Care 1998 11 3 114 119 9729942
  • Lobmann R Zemlin C Motzkau M Reschke K Lehnert H Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing J Diabetes Complications 2006 20 5 329 335 16949521
  • Motzkau M Tautenhahn J Lehnert H Lobmann R Expression of matrix-metalloproteases in the fluid of chronic diabetic foot wounds treated with a protease absorbent dressing Exp Clin Endocrinol Diabetes 2011 119 5 286 290 21031342
  • Veves A Sheehan P Pham HT A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers Arch Surg 2002 137 7 822 827 12093340
  • Marston WA Usala A Hills RS Mendes R Minsley MA Initial report of the use of an injectable porcine collagen-derived matrix to stimulate healing of diabetic foot wounds in humans Wound Repair Regen 2005 13 3 243 247 15953042
  • Blume P Driver VR Tallis AJ Formulated collagen gel accelerates healing rate immediately after application in patients with diabetic neuropathic foot ulcers Wound Repair Regen 2011 19 3 302 308 21371164
  • Ravari H Hamidi-Almadari D Salimifar M Bonakdaran S Parizadeh MR Koliakos G Treatment of non-healing wounds with autologous bone marrow cells, platelets, fibrin glue and collagen matrix Cytotherapy 2011 13 6 705 711 21284564
  • Snyder RJ Richter D Hill ME A retrospective study of sequential therapy with advanced wound care products versus saline gauze dressings: comparing healing and cost Ostomy Wound Manage 2010 56 Suppl 11A S9 15
  • Lázaro-Martinez JL Aragón-Sánchez FJ Garcia-Morales E Beneit-Montesinos JV González-Jurado M A retrospective analysis of the cost-effectiveness of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers Ostomy Wound Manage 2010 56 Suppl 11A S4 8
  • Wu SC Jensen JL Weber AK Robinson DE Armstrong DG Use of pressure offloading devices in diabetic foot ulcers: do we practice what we preach? Diabetes Care 2008 31 11 2118 2119 18694976
  • Fife C Wound care in the 21st century Sancha A US Surgery. 2007 Touch Briefing 2007 63 64 Available from: http://www.touchbriefings.com/pdf/2742/fife.pdf Accessed August 6, 2012
  • Armstrong DG Lavery LA Kimbriel HR Nixon BP Boulton AJ Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen Diabetes Care 2003 26 9 2595 2597 12941724
  • Dowd SE Wolcott RD Sun Y McKeehan T Smith E Rhoads D Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP) PLoS One 2008 3 10 e3326 18833331
  • Gontcharova V Youn E Sun Y Wolcott RD Dowd SE A comparison of bacterial composition in diabetic ulcers and contralateral intact skin Open Microbiol J 2010 4 8 19 20461221
  • Viswanathan V Jasmine JJ Snehalatha C Ramachandran A Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients J Assoc Physicians India 2002 50 1013 1016 12421021
  • Wheat LJ Allen SD Henry M Diabetic foot infections. Bacteriologic analysis Arch Intern Med 1986 146 10 1935 1940 3767539
  • Tarnuzzer R Schultz GS Biochemical analysis of acute and chronic wound environments Wound Repair Regen 1996 4 3 321 325 17177727
  • Robson MC Stenberg BD Heggers JP Would healing alterations caused by infection Clin Plast Surg 1990 17 3 485 492 2199139
  • Ladwig GP Robson MC Liu R Kuhn MA Muir DF Schultz GS Ratios of activated matrix metalloprotease-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers Wound Repair Regen 2002 10 1 26 37 11983004
  • Bucknall T The effect of local infection upon wound healing: an experimental study Br J Surg 1980 67 12 851 855 6160895
  • McGuckin M Goldman R Bolton L Salcido R The clinical relevance of microbiology in acute and chronic wounds Adv Skin Wound Care 2003 16 1 12 25 12582302
  • Dowd SE Wolcott RD Kennedy J Jones C Cox SB Molecular diagnostics and personalised medicine in wound care: assessment of outcomes J Wound Care 2011 20 5 232 234 239 21647068
  • Wolcott RD Cox SB Dowd SE Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics J Wound Care 2010 19 7 272 278 280 281 20616768
  • Wolcott RD Rumbaugh KP James G Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window J Wound Care 2010 19 8 320 328 20852503
  • James GA Swogger E Wolcott R Biofilms in chronic wounds Wound Repair Regen 2008 16 1 37 44 18086294
  • Davis SC Ricotti C Cazzaniga A Welsh E Eaglstein WH Mertz PM Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo Wound Repair Regen 2008 16 1 23 29 18211576
  • Potempa J Pike RN Corruption of innate immunity by bacterial proteases J Innate Immun 2009 1 2 70 87 19756242
  • Massimi I Park E Rice K Muller-Esterl W Sauder D McGavin MJ Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus J Biol Chem 2002 277 44 41770 41777 12207024
  • Boles BR Horswill AR Agr-mediated dispersal of Staphylococcus aureus biofilms PLoS Pathog 2008 4 4 e1000053 18437218
  • Boles BR Thoendel M Roth AJ Horswill AR Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation PLoS One 2010 5 4 e10146 20418950
  • Lauderdale KJ Boles BR Cheung AL Horswill AR Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation Infect. Immun 2009 77 4 1623 1635 19188357
  • Letendre S LaPorta G O’Donnell E Dempsey J Leonard K Pilot Trial of Biovance Collagen-Based Wound Covering for Diabetic Ulcers Advances in Skin & Wound Care 2009 22 4 161 166 19325275
  • Mulder G Tallis A Marshall V Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): Results of a Phase 1/2 trial Wound Rep Reg 2009 17 772 779